Related Experiment Video
Updated: Sep 14, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids
Bingbing Song1, Juan Carlos G Marvizón
1Center for Neurovisceral Sciences and Women's Health, Division of Digestive Diseases, Department of Medicine, Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90095, USA.
Abstract:
To evaluate the effect of peptidases on mu-opioid receptor (MOR) activation by endogenous opioids, we measured MOR-1 internalization in rat spinal cord slices. A mixture of inhibitors of aminopeptidases (amastatin), dipeptidyl carboxypeptidase (captopril), and neutral endopeptidase (phosphoramidon) dramatically increased the potencies of Leu-enkephalin and dynorphin A to produce MOR-1 internalization, and also enhanced the effects of Met-enkephalin and alpha-neoendorphin, but not endomorphins or beta-endorphin. The omission of any one inhibitor abolished Leu-enkephalin-induced internalization, indicating that all three peptidases degraded enkephalins. Amastatin preserved dynorphin A-induced internalization, and phosphoramidon, but not captopril, increased this effect, indicating that the effect of dynorphin A was prevented by aminopeptidases and neutral endopeptidase. Veratridine (30 microm) or 50 mm KCl produced MOR-1 internalization in the presence of peptidase inhibitors, but little or no internalization in their absence. These effects were attributed to opioid release, because they were abolished by the selective MOR antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH(2)) and were Ca(2+) dependent. The effect of veratridine was protected by phosphoramidon plus amastatin or captopril, but not by amastatin plus captopril or by phosphoramidon alone, indicating that released opioids are primarily cleaved by neutral endopeptidase, with a lesser involvement of aminopeptidases and dipeptidyl carboxypeptidase. Therefore, because the potencies of endomorphin-1 and endomorphin-2 to elicit internalization were unaffected by peptidase inhibitors, the opioids released by veratridine were not endomorphins. Confocal microscopy revealed that MOR-1-expressing neurons were in close proximity to terminals containing opioids with enkephalin-like sequences. These findings indicate that peptidases prevent the activation of extrasynaptic MOR-1 in dorsal horn neurons.
Insights
Peptidases degrade endogenous opioids, reducing mu-opioid receptor (MOR) activation. Inhibiting these peptidases enhances opioid potency and MOR-1 internalization in the spinal cord.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Endogenous opioids modulate pain and other physiological processes.
- Mu-opioid receptors (MOR) are key targets for opioid analgesics.
- The role of peptidases in modulating endogenous opioid signaling at MOR is not fully understood.
Purpose of the Study:
- To investigate the impact of peptidases on the activation of mu-opioid receptor 1 (MOR-1) by endogenous opioids.
- To determine which specific peptidases degrade enkephalins and dynorphin A.
- To elucidate the role of peptidases in the regulation of endogenous opioid signaling in the rat spinal cord.
Main Methods:
- Measurement of MOR-1 internalization in rat spinal cord slices.
- Utilized a mixture of peptidase inhibitors: amastatin (aminopeptidases), captopril (dipeptidyl carboxypeptidase), and phosphoramidon (neutral endopeptidase).
- Employing veratridine or KCl to stimulate endogenous opioid release and confocal microscopy to visualize MOR-1 expressing neurons.
Main Results:
- Peptidase inhibitors significantly increased the potency of Leu-enkephalin and dynorphin A for MOR-1 internalization.
- Specific inhibitors revealed that aminopeptidases and neutral endopeptidase degrade dynorphin A, while all three peptidases degrade enkephalins.
- Veratridine-induced MOR-1 internalization, attributed to released opioids, was dependent on Ca(2+) and blocked by CTAP, with neutral endopeptidase being the primary enzyme involved.
Conclusions:
- Peptidases play a crucial role in limiting the activation of extrasynaptic MOR-1 in dorsal horn neurons.
- The degradation of endogenous opioids by peptidases fine-tunes MOR signaling.
- Understanding peptidase activity is vital for developing effective pain management strategies targeting the opioid system.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

